Search Tag: James Noble
2023 06 Jan
Pneumagen, a clinical stage biotech company developing Neumifil, a broad-spectrum antiviral, intranasal drug for the prophylaxis and treatment of viral respiratory tract infections (RTIs), announces the appointment of James Noble as non-executive Chairman of its Board of Directors. James brings over 30 years of industry experience to the Board...Read more